WIIFY Part 3 – Modern Drug Discovery Tools for ex-Pharma Scientists
A four part series exploring the unique challenges of ex-pharma scientists
Part 3 – What’s in it for you, the pure scientist?
You were attracted to science because of the purity of the pursuit. You saw the opportunity to examine nature as it is, as objectively as possible. You saw a way to do some good for science and humankind. Or at least a chance to leave your mark and to be part of the scientific conversation through the ages. You aspire to help discover a drug or be involved in experiments that in the future can help lead to new drugs.
Although in an ideal world you’d be free of monetary and political concerns (it’s why you didn’t become a salesperson, doctor, lawyer, or politician), you are savvy to reality. Everything today must be done on a shoestring budget. Better, faster, cheaper is the modus operandi. There is little breathing room for following up on that curious result. Where is the time for simple, curiosity-driven experimentation? Where is the budget for deeper exploration of the surprising result? It is often the unsettling finding that must be explored further; that is the itch that must be scratched.
Small teams of smart scientists are the only way forward in tight times. With enough ingenuity, you and your team can do some real “damage,” in a good way.
Fortunately, tools have evolved; that is the nature of progress. You and your colleagues can enjoy working together more productively when using collaborative software (CDD Vault) designed for effective sharing and cooperation. When you need biologists to collaborate with chemists, or laboratory experimentalists with computer data addicts, CDD comes to the rescue. CDD provides beautiful software that is enjoyable to use, even for non-experts. You can configure it without any IT experts. And if you do need help, you can contact email@example.com or use the self-serve help forum, or just start clicking around. CDD is so intuitive that you’ll soon be won over, if you aren’t already.